InflaRx (IFRX) Exchange Rate Effect (2016 - 2026)
InflaRx's (IFRX) quarterly Exchange Rate Effect came in at $2.3 million in Q2 2026, up 219.08% year-over-year from $728221.9 in Q2 2025, and up 561.18% quarter-over-quarter from $351429.7 in Q1 2026.
Analysis
InflaRx (IFRX) Exchange Rate Effect (2016 - 2026) Analysis & Trends
InflaRx has disclosed Exchange Rate Effect across 11 years of filings, most recently posting $2.3 million for Q2 2026.
- In Q2 2026, Exchange Rate Effect rose 219.08% year-over-year to $2.3 million; the TTM figure through Jun 2026 stood at $2.5 million (up 184.99% YoY), while the FY2025 annual figure was -$4.1 million, down 368.39% from the prior year.
- Exchange Rate Effect came in at $2.3 million for Q2 2026 at InflaRx, up from $351429.7 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $2.3 million in Q2 2026 to a low of -$2.0 million in Q2 2025.
- Average Exchange Rate Effect over 5 years is $101050.4, with a median of $64410.5 recorded in 2025.
- Year-over-year, Exchange Rate Effect soared 463.79% in 2024 and sank 710.66% in 2025.
- Over 5 years, Exchange Rate Effect stood at -$523806.2 in 2022, then slumped by 60.92% to -$842905.3 in 2023, then soared by 281.52% to $1.5 million in 2024, then plunged by 107.02% to -$107348.1 in 2025, then soared by 2264.54% to $2.3 million in 2026.
- Per Business Quant data, the three most recent Exchange Rate Effect figures were $2.3 million in Q2 2026, $351429.7 in Q1 2026, and -$107348.1 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -19.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | -3.70 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | -300,000.00 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -2.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | -3.40 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 315,000.00 |
| 10 | InflaRx | 139.29 Mn | -44.96 Mn | 2.74 Mn | -22,403.36 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.32 Mn |
| Mar 31, 2026 | 351,429.75 |
| Dec 31, 2025 | -107,348.09 |
| Sep 30, 2025 | -40,102.10 |
| Jun 30, 2025 | -1.95 Mn |
| Mar 31, 2025 | -1.83 Mn |
| Dec 31, 2024 | 1.53 Mn |
| Sep 30, 2024 | -723,771.68 |
| Jun 30, 2024 | 319,540.54 |
| Mar 31, 2024 | 374,122.35 |
| Dec 31, 2023 | -842,905.31 |
| Sep 30, 2023 | 168,923.12 |
| Jun 30, 2023 | -272,283.37 |
| Mar 31, 2023 | -102,841.17 |
| Dec 31, 2022 | -523,806.22 |
| Sep 30, 2022 | 829,689.79 |
| Jun 30, 2022 | 1.96 Mn |
| Mar 31, 2022 | 353,131.22 |
| Dec 31, 2021 | 1.96 Mn |
| Sep 30, 2021 | 2.22 Mn |